全身超音波设备市场（按设备类型、技术、应用和最终用户划分）—2026-2032年全球预测

预计到 2025 年，全身超音波设备市场规模将达到 72.7 亿美元，到 2026 年将成长至 76 亿美元，到 2032 年将达到 103.4 亿美元，复合年增长率为 5.16%。

关键市场统计数据
基准年 2025	72.7亿美元
预计年份：2026年	76亿美元
预测年份 2032	103.4亿美元
复合年增长率 (%)	5.16%

全面介绍全身超音波，阐述技术进步、临床应用驱动因素以及策略决策者在采购方面需要考虑的因素。

全身超音波已从一种小众的辅助诊断手段迅速发展成为核心影像方式，贯穿临床工作流程、照护现场诊断和门诊医疗服务。探头小型化、影像处理技术和电池性能的进步拓展了超音波的应用范围，使临床医生能够将影像检查从放射科转移到床边、诊室和远端地点。因此，采购团队、临床负责人和医疗设备开发人员在选择系统时，面临着影像品质、工作流程整合和整体拥有成本之间相互关联的挑战。

硬体、人工智慧和医疗服务模式的进步如何融合，正在重塑医疗机构中全身超音波的部署、采购和供应商策略？

全身超音波领域正经历变革性的转变，这主要由技术融合、临床需求和组织变革共同驱动。在技​​术方面，先进的波束形成技术、人工智慧驱动的图像优化以及可携式硬体的集成，改变了人们对诊断级系统的预期。这些技术进步辅以更聪明的使用者介面和自动化测量功能，降低了对操作者的依赖性，并将潜在使用者群体扩展到传统超音波之外。

分析近期美国关税如何影响超音波设备买家的筹资策略、供应商选择决策和生命週期成本管理。

到2025年，美国关税和贸易政策调整的累积影响将对全身超音波设备的采购週期、供应商筹资策略和产品定价结构产生新的影响。供应链经理和采购主管必须应对进口商品到岸成本增加、前置作业时间延长以及需要灵活的采购方式来降低风险等挑战。因此，许多企业正在转向供应商网路多元化、加强供应商关係以及强调区域伙伴关係，以提高韧性并缩短补货时间。

详细的細項分析将设备类型、临床应用、最终用户优先事项和核心成像技术与实际的采购和实施选择联繫起来。

主要なセグメメテーション分析により、临床二ズと产品设计・导入経路・商业性的プチーチ接点が器物特性が重要な事件では、カートベーsushisutemuは復雑な影像诊断niーズに适しは復雑ャチネズに适したチャチネチーションreベルの机能を提供し、ハンドヘルドデバイスは分散型环境での迅速な就地检验と携帯性を実现します。また可携式シテムは、混合使用の临床环境において影像性能と机动性のバランをみ临床応用分野において、心臓学构造・机能评估価のための心エコー技术の进歩を用し、筋骨格系イー技术の进歩を用し、筋骨格系イー技术ヂ解像度riniaトランデューサーと动的评価机能の恩恵を受け、产妇人科は信頼性の高いを・骨盘イヂークfuroに依存し、放射线科は全身超音波を多重模式诊断経路に统合し、泌尿系统科は手技后续观察のための标的イメージングを利用し、血管応用分野ではドップラー感度と再现性のある血流测定値が优先されます。エンドユーザーは购入基准とサービス期待に影响を与えます。门诊护理环境优先考虑成本、易用性和吞吐量；诊断中心优先考虑吞吐量和计费优化；医院需要广泛的影像模式支援、与企业级影像系统的整合以及完善的服务协议。此外，技术细分也是一项竞争优势：多普勒成像对于血流评估至关重要，二维成像仍然是结构可视化的基础，而三维/四维成像功能则拓展了其在产科、手术规划和容积分析等领域的应用。透过将这些细分维度与临床工作流程和采购因素结合，相关人员可以确定产品特性和商业模式最符合实际需求的领域。

深入分析美洲、欧洲、中东和非洲以及亚太地区在采用路径、报销机制和服务需求方面的差异，提供关键的区域性洞察。

区域趋势是技术商业化、规模化和整合到医疗服务路径中的核心所在。在美洲，医疗系统日益重视拓展门诊服务能力，因此便携性、快速部署和随时随地培训成为采购者的首要考量。私人和公共支付方的结构影响采购週期和报销奖励，进而影响临床医生偏好的设备和支援模式。在欧洲、中东和非洲，法规环境的差异和医疗基础设施的不均衡，使得适应性和模组化成为竞争优势。能够提供可扩展平台、多语言培训和灵活资金筹措方案的供应商，更有能力满足不同医疗机构的需求。在亚太地区，数位科技的快速普及、对照护现场能力的大力投资以及不断壮大的供应商生态系统，正在推动价格/性能比和社区服务网络领域的激烈竞争。每个地区的技术吸收率、劳动力发展模式和资本配置重点各不相同。因此，成功的商业策略需要根据当地的临床工作流程、报销实际情况和服务预期，量身订做市场推广方案。了解这些区域差异，可以更有效地使您的产品蓝图与您的市场推广计划保持一致。

供应商行为的策略竞争概览，其中平台整合、利基创新和服务模式将决定差异化和长期商业性成功。

公司发展趋势反映了平台投资、细分市场专业化和策略联盟的综合影响，这些因素正在影响企业的竞争地位。主要企业正致力于建立硬体、软体分析和服务一体化的生态系统，以创造差异化的临床工作流程和持续的商机。同时，规模较小的创新者则专注于携带式设备、专用应用或独特的成像方式，透过在特定临床路径中提供针对性价值来挑战现有企业。设备製造商和软体开发商之间的合作正在加速人工智慧驱动的测量工具、工作流程自动化和云端影像管理的部署，而与经销商和临床培训机构的合作则正在将业务拓展到新的临床领域。

为製造商、医疗系统和经销商提供切实可行的、优先排序的建议，以将技术优势转化为持续的临床应用和商业性优势。

针对行业领导者的具体建议着重于协调产品开发、商业策略和临床合作，以加速产品普及并最大化价值。首先，优先考虑模组化设计和软体可升级性，以延长设备生命週期并快速回应不断变化的临床需求。其次，投资以临床医生为中心的培训和资质认证流程，以减少影像撷取和解读的差异，进而提高非传统使用者的可靠性。第三，制定清晰的服务和支援提案，结合预防性保养、快速的零件供应和以结果为导向的培训，以最大限度地减少营运中断。

本分析所依据的稳健调查方法，结合了初步质性访谈、二次文献检验和资料三角验证，从而得出可操作和检验的研究结果。

本分析的调查方法结合了与主题专家、临床医生、采购负责人和行业高管进行的定性研究，以及对同行评审文献、监管文件和行业技术规范等资讯的严谨的二次综合分析。主要访谈旨在探讨临床工作流程、决策标准和服务期望，确保所获得的见解反映的是实际操作情境而非理论能力。二次研究则检验了技术趋势、监管动态以及支持临床效用的已发表证据。

总之，我们综合分析了技术进步、临床应用模式和策略采购考量如何共同决定全身超音波的未来发展轨迹。

总之，全身超音波正处于技术成熟与不断变化的临床和操作需求交汇的转折点。便携性提升、先进的影像处理技术和智慧型使用者介面的协同作用，正在拓展该技术在从门诊到重症监护病房等各种环境中的应用。同时，采购和商业策略必须适应区域趋势、关税主导的供应链变化，以及软体和服务在定义长期价值方面日益增长的重要性。相关人员，将更有利于把创新转化为常规临床应用。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 全身超音波设备市场：依设备分类

• 推车底座
• 手持式
• 可携式的

第九章 全身超音波设备市场：依技术分类

• 多普勒
• 3D/4D
• 2D

第十章 全身超音波设备市场：依应用领域划分

• 心臟病学
• 肌肉骨骼系统
• 妇产科
• 放射科
• 泌尿系统
• 血管

第十一章 全身超音波设备市场（依最终用户划分）

• 门诊护理设施
• 诊断中心
• 医院

第十二章 全身超音波设备市场：依地区划分

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 全身超音波设备市场（依类别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国全身超音波设备市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章美国全身超音波设备市场

第十六章 中国全身超音波设备市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Canon Medical Systems Corporation
• Clarius Mobile Health Corp.
• Esaote SpA
• Fujifilm Holdings Corporation
• GE HealthCare Technologies, Inc.
• Hitachi, Ltd.
• Konica Minolta, Inc.
• Koninklijke Philips NV
• Mindray Medical International Limited
• Samsung Medison Co., Ltd.
• Siemens Healthineers AG

The Whole Body Ultrasound Equipment Market was valued at USD 7.27 billion in 2025 and is projected to grow to USD 7.60 billion in 2026, with a CAGR of 5.16%, reaching USD 10.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 7.27 billion
Estimated Year [2026]	USD 7.60 billion
Forecast Year [2032]	USD 10.34 billion
CAGR (%)	5.16%

Comprehensive introduction to whole body ultrasound that frames technological evolution, clinical adoption drivers, and procurement considerations for strategic decision-makers

Whole body ultrasound has rapidly evolved from a niche diagnostic adjunct to a core imaging modality that intersects clinical workflows, point-of-care diagnostics, and ambulatory care delivery. Advances in probe miniaturization, image processing, and battery performance have broadened the contexts in which ultrasound can be used, enabling clinicians to move imaging from the radiology suite to bedside, clinic rooms, and remote settings. As a result, procurement teams, clinical leaders, and device innovators face interconnected pressures to balance image quality, workflow integration, and total cost of ownership when selecting systems.

Moreover, parallel developments in software-driven image enhancement, cloud-native data management, and regulatory harmonization have changed how institutions evaluate vendor roadmaps and lifecycle support. Clinical adoption patterns now prioritize modalities that reduce time-to-diagnosis and improve throughput without compromising diagnostic confidence. Consequently, stakeholders must consider not only device specifications but also interoperability, training pathways, and support models that drive sustained clinical use. In this landscape, an informed introduction synthesizes technological evolution with operational realities to frame strategic decisions about equipment acquisition, staff training, and partnership opportunities.

How converging advancements in hardware, AI, and care delivery models are reshaping whole body ultrasound adoption, procurement, and vendor strategies across care settings

The landscape for whole body ultrasound is undergoing transformative shifts driven by convergent technology, clinical need, and organizational change. On the technology axis, the integration of advanced beamforming, AI-enabled image optimization, and portable hardware has shifted expectations for what constitutes a diagnostic-grade system. These technical advances are complemented by smarter user interfaces and automated measurements that reduce operator dependency, thereby expanding the pool of potential examiners beyond traditional sonographers.

Clinically, rising demand for point-of-care diagnostics and value-based care models is prompting clinicians to prioritize modalities that accelerate diagnosis, reduce downstream testing, and enable longitudinal monitoring. Operationally, health systems are reallocating imaging capacity to meet outpatient demand while balancing staffing constraints and budgetary pressures. Concurrently, vendor strategies are evolving toward platform-based offerings that bundle devices, software subscriptions, and services to create sticky commercial relationships. Taken together, these transformative shifts create a market where agility, interoperability, and evidence of clinical effectiveness determine which technologies scale across diverse care pathways.

Analyzing how recent United States tariff measures have reshaped procurement strategies, supplier sourcing decisions, and lifecycle cost management for ultrasound buyers

In 2025 the cumulative impact of tariffs and trade policy adjustments in the United States has introduced new considerations for procurement cycles, vendor sourcing strategies, and product pricing structures for whole body ultrasound equipment. Supply chain managers and purchasing directors must navigate increased landed costs for imports, extended lead times, and the need for more flexible sourcing to mitigate exposure. As a result, many organizations are shifting toward diversified supplier networks, closer supplier relationships, and increased emphasis on regional partnerships that can improve resilience and shorten replenishment horizons.

At the same time, vendors face choices about where to allocate manufacturing capacity and which product lines to prioritize for domestic assembly versus offshore production. These decisions have downstream consequences for warranties, spare parts availability, and service networks. Healthcare providers respond by negotiating total cost agreements that cover lifecycle services and by demanding clearer transparency around component sourcing. Consequently, tariffs have become a persistent part of procurement risk assessments, influencing contract terms, inventory policies, and strategic vendor selection without altering the fundamental clinical value proposition of ultrasound as a versatile diagnostic tool.

In-depth segmentation insights connecting equipment typologies, clinical applications, end-user priorities, and core imaging technologies to practical purchasing and deployment choices

Key segmentation insights reveal where clinical needs intersect with product design, adoption pathways, and commercial approaches. When equipment distinctions matter, cart based systems deliver high-channel counts and workstation-level capabilities suitable for complex imaging needs, handheld devices enable rapid point-of-care screening and portability for decentralized settings, and portable systems strike a balance between image performance and mobility for mixed-use clinical environments. Across clinical applications, cardiology leverages echocardiographic advancements for structural and functional assessment, musculoskeletal imaging benefits from high-resolution linear transducers and dynamic assessment capabilities, obstetrics and gynecology depend on reliable fetal and pelvic imaging workflows, radiology integrates whole body ultrasound into multimodality diagnostic pathways, urology uses targeted imaging for procedural guidance and surveillance, and vascular applications prioritize Doppler sensitivity and reproducible flow metrics. End users influence purchase criteria and service expectations; ambulatory care settings emphasize cost, ease-of-use, and throughput, diagnostic centers prioritize throughput and billing optimization, and hospitals require broad modality support, integration with enterprise imaging systems, and robust service agreements. Finally, technology segmentation informs competitive differentiation: Doppler remains essential for flow assessment, Two D imaging continues to be the foundation for structural visualization, and Three D/Four D capabilities expand obstetric, surgical planning, and volumetric analysis use cases. By mapping these segmentation axes to clinical workflows and procurement drivers, stakeholders can identify where product features and commercial models align most closely with real-world needs.

Critical regional insights detailing how the Americas, Europe Middle East and Africa, and Asia-Pacific evolve differently in adoption pathways, reimbursement, and service requirements

Regional dynamics are central to how technologies commercialize, scale, and integrate into care pathways. In the Americas, healthcare systems are increasingly focused on outpatient capacity expansion, making portability, rapid deployment, and site-agnostic training high-priority considerations for buyers. Private and public payer structures shape procurement cycles and reimbursement incentives, which in turn influence the devices and support models preferred by clinicians. Across Europe, Middle East & Africa, varied regulatory environments and heterogeneous healthcare infrastructure create a market where adaptability and modularity are competitive advantages; vendors that provide scalable platforms, multi-language training, and flexible financing options are better positioned to serve diverse institutional profiles. In the Asia-Pacific region, rapid digital adoption, strong investment in point-of-care capabilities, and a growing supplier ecosystem drive intense competition on price-performance and localized service networks. Each region exhibits different rates of technology absorption, workforce training models, and capital allocation priorities, so successful commercial strategies tailor go-to-market approaches to local clinical workflows, reimbursement realities, and service expectations. Understanding these regional contours enables more effective alignment between product roadmaps and market entry plans.

Strategic competitive overview of supplier behaviors showing how platform integration, niche innovation, and service models determine differentiation and long-term commercial success

Company dynamics reflect a mix of platform investment, niche specialization, and strategic partnerships that influence competitive positioning. Leading manufacturers focus on integrated ecosystems that combine hardware, software analytics, and services to create differentiated clinical workflows and recurring revenue opportunities. At the same time, smaller innovators concentrate on handheld devices, focused applications, or unique imaging modalities that challenge incumbents by offering targeted value in specific clinical pathways. Partnerships between device makers and software developers accelerate the delivery of AI-driven measurement tools, workflow automation, and cloud-enabled image management, while alliances with distributors and clinical training providers extend reach into new care settings.

Service models and aftermarket support are increasingly decisive in procurement decisions, as customers evaluate not only initial acquisition cost but also uptime guarantees, spare part logistics, and training programs that ensure sustained clinical utility. Competitive strategies also vary by region, with some companies prioritizing direct sales and service in mature markets and indirect distribution through local partners in emerging regions. Overall, the competitive landscape rewards firms that demonstrate clinical evidence, offer seamless interoperability, and provide credible long-term support commitments.

Practical and prioritized recommendations for manufacturers, health systems, and distributors to convert technological strengths into sustained clinical adoption and commercial advantage

Actionable recommendations for industry leaders focus on aligning product development, commercial strategy, and clinical engagement to accelerate adoption and maximize value. First, prioritize modular design and software upgradability to extend device lifecycles and respond rapidly to evolving clinical requirements. Second, invest in clinician-centered training and credentialing pathways that reduce variability in image acquisition and interpretation, thereby increasing confidence among non-traditional users. Third, develop clear service and support propositions that bundle preventative maintenance, rapid parts logistics, and outcome-oriented training to reduce total operational disruption.

Moreover, pursue strategic partnerships that combine hardware strengths with analytics and informatics capabilities to deliver measurable workflow improvements. From a commercial perspective, tailor go-to-market models to regional reimbursement practices and procurement cycles, offering flexible financing and subscription options where capital constraints exist. Finally, incorporate supply chain resilience into product planning by diversifying component sources and strengthening regional service hubs to minimize lead-time exposure. Together, these recommendations create a pragmatic roadmap for leaders to convert technological capability into sustained clinical and commercial impact.

Robust research methodology integrating primary qualitative interviews, secondary literature validation, and data triangulation to produce actionable and verifiable insights

The research methodology underpinning this analysis combines primary qualitative engagement with domain experts, clinicians, procurement officers, and industry executives alongside rigorous secondary-source synthesis from peer-reviewed literature, regulatory documents, and industry technical specifications. Primary interviews were structured to explore clinical workflows, decision criteria, and service expectations, ensuring insights reflect operational realities rather than theoretical capability. Secondary research validated technological trends, regulatory developments, and published evidence supporting clinical utility.

Data triangulation was applied to reconcile differing perspectives and to surface consensus where it exists, with special attention to device performance attributes, training requirements, and service model impacts. Throughout the process, care was taken to avoid reliance on single-source estimates or proprietary databases alone; instead, findings emphasize reproducible observations and documented industry practice. This methodology supports actionable conclusions by grounding strategic implications in a blend of practitioner experience and verifiable technical documentation.

Conclusion synthesizing how technological progress, clinical adoption patterns, and strategic procurement considerations collectively define the future trajectory of whole body ultrasound

In conclusion, whole body ultrasound stands at an inflection point where technological readiness meets evolving clinical and operational demands. The combined effects of improved portability, enhanced image processing, and smarter user interfaces are expanding the modality's role across settings that range from ambulatory clinics to high-acuity hospital departments. At the same time, procurement and commercial strategies must adapt to regional dynamics, tariff-driven supply chain shifts, and the growing importance of software and services in defining long-term value. Stakeholders who align product design with clinician needs, invest in training and support, and build resilient supply and service networks will be best positioned to translate innovation into routine clinical use.

Sustained success requires an integrated approach that balances hardware performance, software capability, and credible service promises. For industry participants, the path forward lies in demonstrating clinical impact, ensuring regulatory preparedness, and partnering effectively with care providers to embed ultrasound into standard diagnostic pathways. By focusing on these areas, organizations can help realize the full clinical and economic potential of whole body ultrasound across diverse healthcare environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Whole Body Ultrasound Equipment Market, by Equipment Type

• 8.1. Cart Based
• 8.2. Handheld
• 8.3. Portable

9. Whole Body Ultrasound Equipment Market, by Technology

• 9.1. Doppler
• 9.2. Three D/Four D
• 9.3. Two D

10. Whole Body Ultrasound Equipment Market, by Application

• 10.1. Cardiology
• 10.2. Musculoskeletal
• 10.3. Obstetrics & Gynecology
• 10.4. Radiology
• 10.5. Urology
• 10.6. Vascular

11. Whole Body Ultrasound Equipment Market, by End User

• 11.1. Ambulatory Care Settings
• 11.2. Diagnostic Centers
• 11.3. Hospitals

12. Whole Body Ultrasound Equipment Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Whole Body Ultrasound Equipment Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Whole Body Ultrasound Equipment Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Whole Body Ultrasound Equipment Market

16. China Whole Body Ultrasound Equipment Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Canon Medical Systems Corporation
• 17.6. Clarius Mobile Health Corp.
• 17.7. Esaote S.p.A.
• 17.8. Fujifilm Holdings Corporation
• 17.9. GE HealthCare Technologies, Inc.
• 17.10. Hitachi, Ltd.
• 17.11. Konica Minolta, Inc.
• 17.12. Koninklijke Philips N.V.
• 17.13. Mindray Medical International Limited
• 17.14. Samsung Medison Co., Ltd.
• 17.15. Siemens Healthineers AG

LIST OF FIGURES

• FIGURE 1. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CART BASED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CART BASED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CART BASED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY THREE D/FOUR D, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY THREE D/FOUR D, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY THREE D/FOUR D, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TWO D, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TWO D, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TWO D, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 52. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 53. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 54. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 55. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 56. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 57. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 58. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 59. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 60. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 61. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 62. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 64. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 65. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 66. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 67. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 68. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 69. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 70. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 71. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 72. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 73. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 74. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 75. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 76. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 77. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 78. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 79. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 80. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 81. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 82. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 83. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 84. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 85. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 86. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 87. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 88. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 89. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 90. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 91. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 92. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 93. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 94. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 95. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 96. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 97. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 98. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 99. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 100. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 101. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 102. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 103. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 104. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 105. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 106. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 107. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 108. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 109. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 110. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 111. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 112. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 113. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 114. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 115. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 116. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 117. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 119. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 120. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 121. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 122. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 123. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 124. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 125. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 126. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 127. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 128. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 129. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 130. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 131. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 132. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 133. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)